FDA COMMUNICATIONS Oversight

First Page		Document Content
Date: 2013-04-03 13:09:17 Clinical research Medicine Advertising Direct-to-consumer advertising Fleishman-Hillard International Communications Pharmaceutical marketing Pharmaceutical industry Investigational New Drug Off-label use Pharmacology Pharmaceutical sciences Food and Drug Administration		FDA COMMUNICATIONS Oversight Add to Reading List Source URL: www.eyeonfda.com Download Document from Source Website File Size: 1.021,24 KB Share Document on Facebook

	For Immediate Distribution For more information: Geoff Mordock Fleishman-Hillard International Communications DocID: 1pAbC - View Document
	excellence_winners_2009.indd DocID: 15SzP - View Document
	excellence_shortliste_gewinner.indd DocID: 15PJw - View Document
	PDF Document DocID: 15fQ2 - View Document
	935075_ExecSum_050407.indd DocID: 134vY - View Document